FDA Guidance for Industry: FDA’s Application of Statutory Factors in Determining When a REMS Is Necessary

Titel:
FDA Guidance for Industry: FDA’s Application of Statutory Factors in Determining When a REMS Is Necessary
Herkunft/Verlag:

FDA, http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM521504.pdf

Inhalt:
This guidance is intended to clarify how the Food and Drug Administration (FDA or Agency) applies the factors set forth in section 505-1 of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (21 U.S.C. 355-1) in determining whether a risk evaluation and mitigation strategy REMS) is necessary to ensure that the benefits of a drug outweigh its risks

Zurück

GMP Seminare nach Thema